Serial 18F-choline-PET imaging in patients receiving enzalutamide for metastatic castration-resistant prostate cancer: response assessment and imaging biomarkers

Future Oncology Ahead of Print.


from Cancer via ola Kala on Inoreader http://ift.tt/1n7Hu9a
via IFTTT